Icare USA’s iCare Home2 Self-Tonometer Wins FDA’s 510(k) Clearance

Icare USA has received the FDA’s 510(k) clearance for its iCare Home2 self-tonometer, a device for measuring glaucoma patients’ intraocular pressure. 

Most patients can use the device on their own by following the interactive display screen, the Raleigh, N.C.-based company says. The device lets patients take measurements while they are supine, reclining or sitting.

The tonometer uploads the intraocular pressure data to the company’s cloud-based iCare Clinic, which sends it to healthcare professionals for review.